Dai L - Search Results

1

Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer.

Yin J, Hu W, Xue X, Fu W, Dai L, Jiang Z, Zhong S, Deng B, Zhao J. Yin J, et al. Among authors: dai l. J Cancer. 2019 Aug 28;10(21):5070-5081. doi: 10.7150/jca.30034. eCollection 2019. J Cancer. 2019. PMID: 31602259 Free PMC article.

2

MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.

Jiang Z, Yin J, Fu W, Mo Y, Pan Y, Dai L, Huang H, Li S, Zhao J. Jiang Z, et al. Among authors: dai l. PLoS One. 2014 Apr 10;9(4):e94639. doi: 10.1371/journal.pone.0094639. eCollection 2014. PLoS One. 2014. PMID: 24722426 Free PMC article.

3

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.

Zhao J, Fu W, Liao H, Dai L, Jiang Z, Pan Y, Huang H, Mo Y, Li S, Yang G, Yin J. Zhao J, et al. Among authors: dai l. BMC Cancer. 2015 Oct 19;15:731. doi: 10.1186/s12885-015-1713-z. BMC Cancer. 2015. PMID: 26482648 Free PMC article.

4

Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.

Fu WF, Chen WB, Dai L, Yang GP, Jiang ZY, Pan L, Zhao J, Chen G. Fu WF, et al. Among authors: dai l. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2565-72. Eur Rev Med Pharmacol Sci. 2016. PMID: 27383306 Free article.

5

Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.

Yin J, Zhao J, Hu W, Yang G, Yu H, Wang R, Wang L, Zhang G, Fu W, Dai L, Li W, Liao B, Zhang S. Yin J, et al. Among authors: dai l. PLoS One. 2017 Feb 24;12(2):e0172787. doi: 10.1371/journal.pone.0172787. eCollection 2017. PLoS One. 2017. PMID: 28235063 Free PMC article.

6

ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.

Yin J, Fu W, Dai L, Jiang Z, Liao H, Chen W, Pan L, Zhao J. Yin J, et al. Among authors: dai l. Sci Rep. 2017 Jun 30;7(1):4430. doi: 10.1038/s41598-017-04818-y. Sci Rep. 2017. PMID: 28667340 Free PMC article.

7

let‑7 and miR‑17 promote self‑renewal and drive gefitinib resistance in non‑small cell lung cancer.

Yin J, Hu W, Pan L, Fu W, Dai L, Jiang Z, Zhang F, Zhao J. Yin J, et al. Among authors: dai l. Oncol Rep. 2019 Aug;42(2):495-508. doi: 10.3892/or.2019.7197. Epub 2019 Jun 12. Oncol Rep. 2019. PMID: 31233201 Free PMC article.

8

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer.

Yin J, Hu W, Fu W, Dai L, Jiang Z, Zhong S, Deng B, Zhao J. Yin J, et al. Among authors: dai l. Onco Targets Ther. 2019 Nov 5;12:9227-9237. doi: 10.2147/OTT.S217595. eCollection 2019. Onco Targets Ther. 2019. PMID: 31807006 Free PMC article.

9

Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.

Zhao J, Xue X, Fu W, Dai L, Jiang Z, Zhong S, Deng B, Yin J. Zhao J, et al. Among authors: dai l. Int J Oncol. 2020 May;56(5):1083-1092. doi: 10.3892/ijo.2020.5003. Epub 2020 Mar 4. Int J Oncol. 2020. PMID: 32319573 Free PMC article.

10

Cell adhesion molecule 2 (CADM2) promotes brain metastasis by inducing epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer.

Dai L, Zhao J, Yin J, Fu W, Chen G. Dai L, et al. Ann Transl Med. 2020 Apr;8(7):465. doi: 10.21037/atm.2020.03.85. Ann Transl Med. 2020. PMID: 32395509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,560 results

Search Page

Filters